Canada's total drug spending is estimated to have reached C$29.8 billion ($24.31 billion) in 2008, according to the Canadian Institute for Health Information, a rise of 8.3% versus the previous year. Prescribed medicine costs, accounting for 84% of the total drug bill, rose 9% vs only 4.6% for over-the-counter products.
Michael Hunt, the manager of pharmaceutical programs at the CIHI, said: "over the last 20 years, drugs have consistently remained one of the major cost drivers in health care. Spending on pharmaceuticals has more than doubled over the past 10 years, outpacing growth in health spending by hospitals, physicians and other health professionals."
The aggregate figures hide key differences in the performance of various areas of Canadian health care. For example, the biggest increase in spending on prescription medicines has been in the private sector, up 11% in 2008 to C$14.0 billion, which represents over 55% of the country's Rx expenditure. By contrast, public-sector spending on the same categories of drug was up 6.7%, reaching C$11.2 billion.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze